Quantcast

Latest Sigma Life Science Stories

2011-04-12 07:00:00

ST. LOUIS, April 12, 2011 /PRNewswire/ -- Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq: SIAL), today announced the signing of an agreement with Kraig Biocraft Laboratories, Inc. (KBLB) to develop genetically modified silkworms for the production of spider silk, using Sigma's proprietary CompoZr Zinc Finger Nuclease (ZFN) technology. The transfer of silk genes from the spider to the silkworm is expected to...

2011-03-29 07:30:00

NEW YORK, March 29, 2011 /PRNewswire-USNewswire/ -- AMDeC, LLC today announced continued expansion of its Vendor Partnership Program to include products offered by Sigma® Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq: SIAL). AMDeC is a consortium of pre-eminent academic medical research institutions in the New York region that is focused on increasing efficiencies and encouraging collaboration in...

2011-03-17 07:00:00

ST. LOUIS, March 17, 2011 /PRNewswire/ -- Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq: SIAL), announced that its SAGE Labs initiative has created a suite of knockout rat models of Parkinson's disease in collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF). Developed using the proprietary SAGEspeed(TM) model creation process, these off-the-shelf rat models represent a...

2011-02-24 15:00:00

ST. LOUIS, Feb. 24, 2011 /PRNewswire/ -- Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq: SIAL), today announced the release of its pre-designed CompoZr Knockout Zinc Finger Nucleases (ZFNs) technology to knockout any gene in the human genome. The new offer, attractively priced to fit within the budget of a typical laboratory, can generate permanent and heritable gene knockouts in human cell lines within...

2011-02-02 07:00:00

ST. LOUIS, Feb. 2, 2011 /PRNewswire/ -- Sigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq: SIAL), today announced that its SAGE Labs initiative has partnered with Cofactor Genomics in an effort to sequence genomes for six of the most widely used strains of rat. As part of the agreement, Cofactor Genomics plans to generate and analyze sequence data using next generation sequencing systems, while SAGE Labs plans to...

2010-12-13 00:00:00

ST. LOUIS, Dec. 13, 2010 /PRNewswire-FirstCall/ -- Sigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq: SIAL), today announced that its SAGE Labs initiative has successfully used its proprietary CompoZr® Zinc Finger Nuclease (ZFN) technology to generate knock-in rats in which foreign genes have been inserted, or 'knocked-in', into the rat genome in a precisely targeted manner. This breakthrough...

2010-12-02 16:14:00

ST. LOUIS, Dec. 2, 2010 /PRNewswire/ -- Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq: SIAL), today announced that its genetically modified reporter cell lines - based on the CompoZr zinc finger nuclease (ZFN) technology - takes the silver medal position in The Scientist magazine's Top Ten Innovations for 2010. This latest award continues Sigma Life Science's track record of success in the...

2010-09-02 00:00:00

ST. LOUIS, Sept. 2 /PRNewswire-FirstCall/ -- Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq: SIAL), today announced the global release of a pioneering range of engineered mammalian cell lines. This new product range combines Sigma's proprietary CompoZr zinc finger nuclease (ZFN) technology with the Company's extensive experience in gene silencing, to offer innovative tools for drug discovery,...

2010-08-05 00:00:00

ST. LOUIS, Aug. 5 /PRNewswire-FirstCall/ -- Sigma-Aldrich® (Nasdaq: SIAL) today announced it has entered into an agreement with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, and Boston University (BU) to develop methods to measure several potential biomarkers of atherosclerotic cardiovascular disease (CVD) using plasma samples from the NHLBI's Framingham Heart Study (FHS), one of the most prestigious clinical studies in...

2010-03-25 00:00:00

ST. LOUIS, March 25 /PRNewswire-FirstCall/ -- Sigma® Life Science, the innovative biological products and services brand of Sigma-Aldrich® (Nasdaq: SIAL), today announced details of a corporate partnership with the European Molecular Biology Laboratory (EMBL) Advanced Training Centre, based in Heidelberg, Germany, that officially opened on March 9, 2010. The partnership brings together EMBL's world-class advanced training program with Sigma Life Science...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.